Business Description
Ondine Biomedical Inc
NAICS : 541714
SIC : 3741
ISIN : CA68234M2058
Share Class Description:
LSE:OBI: Common ShareDescription
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.48 | |||||
| Equity-to-Asset | 0.01 | |||||
| Debt-to-Equity | 18.27 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -63.32 | |||||
| Beneish M-Score | -2.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.2 | |||||
| 3-Year EBITDA Growth Rate | 1.6 | |||||
| 3-Year EPS without NRI Growth Rate | 4.4 | |||||
| 3-Year FCF Growth Rate | -29.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 35.13 | |||||
| Future 3-5Y Total Revenue Growth Rate | 125.82 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.48 | |||||
| 9-Day RSI | 45.52 | |||||
| 14-Day RSI | 50.45 | |||||
| 6-1 Month Momentum % | 6.25 | |||||
| 12-1 Month Momentum % | 3.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | |||||
| Quick Ratio | 0.48 | |||||
| Cash Ratio | 0.3 | |||||
| Days Inventory | 645.47 | |||||
| Days Sales Outstanding | 48.97 | |||||
| Days Payable | 647.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.2 | |||||
| Shareholder Yield % | -9.52 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.96 | |||||
| Operating Margin % | -893.57 | |||||
| Net Margin % | -873.24 | |||||
| FCF Margin % | -768.91 | |||||
| ROE % | -670.11 | |||||
| ROA % | -246.17 | |||||
| ROIC % | -491.02 | |||||
| ROC (Joel Greenblatt) % | -1465.07 | |||||
| ROCE % | -594.89 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 20 | |||||
| PB Ratio | 16 | |||||
| Price-to-Tangible-Book | 8 | |||||
| EV-to-EBIT | -4.07 | |||||
| EV-to-Forward-EBIT | -3.7 | |||||
| EV-to-EBITDA | -4.24 | |||||
| EV-to-Forward-EBITDA | -2.05 | |||||
| EV-to-Revenue | 35.41 | |||||
| EV-to-Forward-Revenue | 12.25 | |||||
| EV-to-FCF | -4.61 | |||||
| Earnings Yield (Greenblatt) % | -24.57 | |||||
| FCF Yield % | -21.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ondine Biomedical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 0.949 | ||
| EPS (TTM) (£) | -0.035 | ||
| Beta | 0 | ||
| Volatility % | 82.37 | ||
| 14-Day RSI | 50.45 | ||
| 14-Day ATR (£) | 0.005478 | ||
| 20-Day SMA (£) | 0.083375 | ||
| 12-1 Month Momentum % | 3.03 | ||
| 52-Week Range (£) | 0.05 - 0.114 | ||
| Shares Outstanding (Mil) | 426.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ondine Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ondine Biomedical Inc Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ondine Biomedical Inc Frequently Asked Questions
What is Ondine Biomedical Inc(LSE:OBI)'s stock price today?
The current price of LSE:OBI is £0.08. The 52 week high of LSE:OBI is £0.11 and 52 week low is £0.05.
When is next earnings date of Ondine Biomedical Inc(LSE:OBI)?
The next earnings date of Ondine Biomedical Inc(LSE:OBI) is 2025-06-06 Est..
Does Ondine Biomedical Inc(LSE:OBI) pay dividends? If so, how much?
Ondine Biomedical Inc(LSE:OBI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers